Stable S-(+)-abscisic acid nonaqueous liquid solutions

Abstract

Stable S-(+)-abscisic acid (S-ABA) non-aqueous liquid solutions are generally achieved without the use of an effective amount of an antioxidant and/or an ultraviolet absorber to S-(+)-abscisic acid. In a preferred embodiment, the stable S-(+)-abscisic acid (S-ABA) nonaqueous liquid solutions includes at least one organic solvent, such as at least one polyethylene glycol, at least one glycol, and/or at least one lactamide and/or at least one pentanoate.

Claims

1. A non-aqueous liquid solution comprising: a) about 10 to about 40 wt.% of at least one form of S-(+) abscisic acid (S-ABA); b) about 20 to 90 wt.% of an organic solvent, which is N,N-dimethyl lactamide; c) optionally, 0 to about 50 wt.% of at least one non-aqueous co-solvent; d) optionally, 0 to about 20 wt.% of at least one surfactant; e) optionally, additional plant growth regulator(s); f) optionally, additional plant nutrients; g) less than 0.1 wt.% antioxidant; h) less than 0.1 wt.% UV absorber; and i) 5 wt.% water; wherein the average amount of S-ABA does not decline to less than 95% of the average content measured prior to storage stability performed at 54±2° C. for 14 days.

2. The solution of claim 1, comprising 60-90 wt.% N,N-dimethyl lactamide as the organic solvent.

3. The solution of claim 2, wherein the at least one form of S-(+) abscisic acid is 2-cis,4-trans-(S)-abscisic acid.

4. The solution of claim 3, comprising ≤2 wt.% water.

5. The solution of claim 1, wherein said UV absorber is selected from the group consisting of benzophone-3, ethylhexyl methoxycinnamate, and mixtures thereof.

6. The solution of claim 5, wherein said UV absorber is benzophone-3.

7. The solution of claim 5, wherein said UV absorber is ethylhexyl methoxycinnamate.

8. The solution of claim 1, wherein said antioxidant is selected from the group consisting of t-butylhydroquinone (TBHQ), propyl gallate, clove oil, ethoxyquin, and mixtures thereof.

9. The solution of claim 8, wherein said antioxidant is t-butylhydroquinone (TBHQ).

10. The solution of claim 1, comprising ≤1 wt.% water.

11. The solution of claim 1, comprising 8-30 wt.% of at least one non-aqueous co-solvent.

12. The solution of claim 1, comprising ≤25 wt.% plant growth regulator(s).

13. The solution of claim 1, comprising ≤25 wt.% additional plant nutrients.

14. A non-aqueous liquid solution comprising: a) about 10 to about 40 wt.% of at least one form of S-(+) abscisic acid (S-ABA); b) about 60 to 90 wt.% of an organic solvent, which is N,N-dimethyl lactamide; c) 8-30 wt.% of at least one non-aqueous co-solvent; d) optionally, 0 to about 20 wt.% of at least one surfactant; e) 25 wt.% plant growth regulator(s); f) 25 wt.% additional plant nutrients; g) less than 0.1 wt.% antioxidant; h) less than 0.1 wt.% UV absorber; and i) 2 wt.% water; wherein said non-aqueous liquid solution has a stability performance of ±5% for S-ABA in said non-aqueous liquid solution when subjected to an elevated temperature of 54° C. for 14 days.

15. The solution of claim 14, wherein said UV absorber is selected from the group consisting of benzophone-3, ethylhexyl methoxycinnamate, and mixtures thereof.

16. The solution of claim 14, wherein said antioxidant is selected from the group consisting of t-butylhydroquinone (TBHQ), propyl gallate, clove oil, ethoxyquin, and mixtures thereof.

17. The solution of claim 14, wherein the at least one form of S-(+) abscisic acid is 2-cis, 4-trans-(S)-abscisic acid.

18. The solution of claim 16, comprising about 16 to about 40 wt. % of at least one form of S-(+) abscisic acid (S-ABA).

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) The features and advantages of the present invention will become apparent from the following detailed description of a preferred embodiment thereof, taken in conjunction with the accompanying drawings, in which:

(2) FIG. 1 is a graph showing the anthocyanin content in grapes for a control treatment, commercial treatment, and treatment with the present invention (“Stoller”).

DETAILED DESCRIPTION OF THE INVENTION

(3) The present invention relates to stable S-(+)-abscisic acid nonaqueous liquid solutions and methods of using these solutions to improve the storage and light stability of 2-cis,4-trans-(S)-abscisic acid. More specifically, the present invention relates to methods of improving the storage stability and the photochemical stability of 2-cis,4-trans-(S)-abscisic acid in a nonaqueous solution without the addition of an effective amount of at least one antioxidant and/or an ultraviolet (UV) absorber to the solution.

(4) In a preferred embodiment, the stable S-(+)-abscisic acid (S-ABA) nonaqueous liquid solution includes about 20 to 99.9 wt.% of at least one organic solvent. Preferably, the organic solvent is at least one polyethylene glycol, or at least one glycol, or at least one lactamide, or at least one pentanoate. In one embodiment, the organic solvent is a low volatile organic compounds (VOC) solvent. Low VOC stable liquid formulations are generally achieved by using a low VOC solvent system. On May 30, 2006, the California Department of Pesticide Regulation (DPR) announced an air quality initiative to reduce pesticide-related emissions of volatile organic compounds (VOC). All pesticide formulations sold in California require <30% VOC content as estimated by thermogravimetry analysis (TGA). Therefore, a low VOC solvent system designated above would meet the DPR requirements. Generally, the nonaqueous liquid solution of the present invention has a low level of volatile organic chemicals such that the vapor pressure of the nonaqueous liquid solution is less than 0.08 mm Hg at 20° C. or the nonaqueous liquid solution has a volatile organic chemical (VOC) emission potential of 25%.

(5) Preferred low VOC solvent systems are based upon high boiling point solvents such as polyethylene glycol of equal or less than 400 molecular weight, preferably 190-400 molecular weight, preferably 190-310 molecular weight, and more preferable 190-210 molecular weight. Low VOC solvents such as polyethylene glycol (PEG 200) can be used in the nonaqueous liquid solution of the present invention. A mixture of PEG 200 with other polar aprotic solvents can also be used. Such polar aprotic solvents include, but are not limited to alcohols, dialkyl ketones, alkylene carbonates, alkyl esters, and aryl esters.

(6) In one embodiment, the nonaqueous liquid solution includes at least one non-aqueous co-solvent. The non-aqueous co-solvents are selected from the group consisting of ethanol, n-propanol, iso-propanol, ethyl lactate, 3 ethyl hydroxybutrate, 3 propyl hydroxybutyrate, glycols, glycerols, polyethylene glycols, polypropylene glycols, propylene carbonates, lactamides, pentanoates and further combinations thereof. In one embodiment, the nonaqueous liquid solution includes 0 to about 50 wt.% non-aqueous co-solvent.

(7) Abscisic acid is an optically active 15-C weak acid with 8′, 9′ and 10′ CH3 groups in the ring. The structural formula of abscisic acid is set forth below:

(8) ##STR00001##

(9) The nonaqueous liquid solution of the present invention utilize the S-(+) enantiomer rather than a racemic mixture of stereoisomers. Unless expressly stated otherwise, in all instances when the application refers to abscisic acid, it refers to S-(+)-abscisic acid.

(10) As used herein, the term “antioxidant” means any chemical or biological compound or substance that inhibits oxidation. Antioxidants include, but are not limited to, t-butylhydro-quinone (TBHQ), propyl gallate, clove oil, and/or ethoxyquin.

(11) As used herein, the term “UV absorber” means any chemical compound or substance that acts to absorb UV light in order to reduce the degradation and the isomerization of 2-cis,4-trans-(S)-ABA caused by UV radiation. UV absorbers include, but are not limited to, benzophone-3 and/or ethylhexyl methoxycinnamate.

(12) The phrase “effective amount” of an antioxidant or an ultraviolet absorber means a nontoxic but sufficient amount of antioxidant or UV absorber to provide the desired effect. The amount of antioxidant or ultraviolet absorber that is “effective” will vary from composition to composition, depending on the particular composition, the particular antioxidant or ultraviolet absorber, and the like. Thus, it is not always possible to specify an exact “effective amount.” However, an appropriate “effective amount” in any individual case may be determined by one of ordinary skill in the art using routine experimentation. This amount is generally at least 0.1 weight % of the antioxidant and at least 0.1 weight % UV absorber based upon the total weight of the solution.

(13) A preferred nonaqueous liquid solution of the present invention comprises from 0.001 to 40 weight % of at least one form of abscisic acid, such as S-ABA, or 0.001 to 25 weight.%, or 1 to 25 weight %, or 1 to 20.5 weight %, or 0.001 to 10 weight%. These nonaqueous liquid solutions include less than 0.1 wt.% antioxidant, or less than 0.08 wt.% antioxidant, or less than 0.05 wt.% antioxidant; and less than 0.1 wt.% UV absorber, or less than 0.08 wt.% UV absorber, or less than 0.05 wt.% UV absorber. The nonaqueous liquid solution can also contain from 0 to 20 weight % surfactant and will contain from 75 to 99.9 weight % of at least one organic solvent, or 50-80 wt.% of at least one organic solvent, or 75-95 wt.% of at least one organic solvent. The nonaqueous liquid solution can also contain from 0 to 50 weight % co-solvent. The nonaqueous liquid solution can then be diluted prior to use as is well known in the art to apply an effective amount of S-ABA to plants being treated as is hereinafter discussed.

(14) In one embodiment of the present invention, the nonaqueous liquid solution includes about 10-20.5 wt.% of one form of ABA, such as S-ABA, and about 79.5-90 wt.% polyethylene glycol.

(15) The term “nonaqueous” means that the stable nonaqueous liquid solution contains ≤10 wt.% water, more preferably ≤5 wt. % water, more preferably ≤2.5 wt.% water, and more preferably ≤1 wt.% water.

(16) In a preferred embodiment, the stable nonaqueous liquid solution would also include an effective amount of a surfactant to improve wetting, spray retention and penetration of S-ABA in use dilutions. In one embodiment, the nonaqueous liquid solution includes 0 to about 20 wt.% of at least one surfactant. The surfactant includes, but are not limited to, the group consisting of carboxylates, sulfonates, natural oils, alkylamides, arylamides, alkylphenols, arylphenols, ethoxylated alcohols, polyoxygethylene, carboxylic esters, polyalkylglycol esters, anhydrosorbitols, glycol esters, carboxylic amides, monoalkanolamine, poloxyethylene fatty acid amides, polysorbates, cyclodextrins, sugar based, silicone based, polyalkylated alcohols, and alkylaryl ethoxylates. Surfactants that could be used include, but are not limited to, sorbitan derivatives such as Tween® 80, Tween®85 (Tween® is a registered trademark of Croda Americas, Inc., Tween®80 and 85 are available from Croda, Inc.), ethoxylated alcohols such as Brij®98 (Brij® is a registered trademark of Uniqema Americas LLC, Brij® 98 is available from Croda Inc.), ethoxylated alkylphenols such as Igepol CA-630, Igepol, and Igepol CO-630 from Rhodia Inc., ethoxylated fatty acids such as Myrj® 52 (Myrj® is a registered trademark of Atlas Powder Company, Myrj® 52 is available from Croda Inc.), silicone based surfactants such as Silwet L-77® (Silwet and Silwet L-77 are registered trademarks of Momentive Performance Chemicals, Silwet L-77® is available from Momentive Performance Chemicals), and block polymeric surfactants such as Pluronic® P85 and Pluronic® P104 (Pluronic is a registered trademark of BASF Corporation, Pluronic® P85 and P104 are available from BASF Corporation).

(17) It should be understood the recitation of a range of values includes all of the specific values in between the highest and lowest value. For example, the recitation of “0.001 to 40 weight % S-ABA” includes all of the values between about 0.001 to about 40 such that either the upper or lower limits may include, but are not limited to, 0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, and 40. For example, the recitation of “less than 0.1 wt.%” antioxidant and UV absorber, includes all of the values between 0-0.1 wt.% such that either the upper or lower limits may include, but are not limited to, 0, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09 and 0.10. For example, the recitation of “0 to 20 weight % surfactant” includes all of the values between 0 and 20 such that either the upper or lower limits may include, but are not limited to, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20. For example, the recitation of “20 to 99.9 weight %” organic solvent includes all of the values between 20 and 99.9 such that either the upper or lower limits may include, but are not limited to, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78 ,79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 and 99.9. For example, the recitation of “less than 10 wt.% water” includes all of the values between 0 and 10 wt.% such that either the upper or lower limits may include, but are not limited to, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10. For example, the recitation of “0 to about 50 wt.% non-aqueous co-solvent” and includes all of the values between 0 and 50 such that either the upper or lower limits may include, but are not limited to, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 and 50.

(18) In another embodiment, the present invention also relates to liquid solutions comprising an effective amount of 2-cis,4-trans-(S)-abscisic acid and an effective amount of another plant growth regulator and/or another plant nutrient. Preferably, this solution does not include an effective amount of any antioxidant and/or UV stabilizer. In a preferred embodiment, the other plant growth regulator is selected from the group consisting of gibberellic acid (GA.sub.3), 6-benzyladenine (6-BA), Kinetin, Indole-3-Butyric Acid (IBA), Indole-3-Acetic Acid (IAA), Salicylic acid (SA) and/or N-(2-chloro-4-pyridinyl)-N′-phenylurea (CPPU). In a preferred embodiment, the other plant nutrient is selected from a group of compounds including nitrogen, phosphorus, potassium, calcium, magnesium, sulfur, boron, copper, iron, manganese, molybdenum, and/or zinc. For example, the plant nutrient may be boric acid and/or sodium molybdate. The mixtures of S-ABA with other plant growth regulators can improve plant growth, crop yield, stress tolerance, and disease resistance, as well as promote floral bud initiation and flowering. In a preferred embodiment, the liquid solution includes ≤25 wt.% additional plant growth regulators, or ≤20 wt.%, or ≤15 wt.%, or ≤10 wt.%, or ≤5 wt.%, or ≤1 wt.%. In a preferred embodiment, the liquid solution includes ≤25 wt.% additional plant nutrients, or ≤20 wt.%, or ≤15 wt.%, or ≤10 wt.%, or ≤5 wt.%, or ≤1 wt.%.

(19) Nonaqueous liquid solutions of the present invention can be prepared as either ready-to-use dilutions or dilutable concentrates. The dilutable concentrates can be diluted to a final application concentration or to any intermediate dilution, without risk of precipitation of the active ingredient. The nonaqueous liquid solutions according to the present invention are inexpensive to manufacture, stable under storage and shipping conditions, and are safe to handle and use. A person having ordinary skill in the art would be able to determine how to prepare the dilutions without undue experimentation.

(20) (S)-(+)-abscisic acid has various agricultural applications. For example, formulations of this invention may be used to improve stress tolerance of plants, slow the growth rate, adjust the flowering phase, treat seeds, inhibit the growth of stalk leaf, prevent pre-harvest fruit and flower drop, improve the quality and color of fruits, etc. It is beneficial and highly useful for nonaqueous liquid formulations of abscisic acid to be stable for a long period of time, saving the end user's time and money associated with buying new formulations. Possible uses would include, for example, distribution and sale of nonaqueous liquid solutions comprising (S)-(+)-abscisic acid without effective amounts of any antioxidant and/or any UV absorber according to the present invention. The end user could then store the nonaqueous liquid solution for a prolonged period of time.

(21) As used herein, all numerical values relating to amounts, weight percentages and the like, are defined as “about” or “approximately” each particular value plus or minus 10%. For example, the phrase “greater than 0.1%” is to be understood as encompassing values greater than 0.09%. Therefore, amounts within 10% of the claimed values are encompassed by the scope of the claims.

(22) In a preferred embodiment, the non-aqueous liquid solution comprises, consists of, or consists essentially of: a) about 0.001 to about 40 wt. %, or about 0.001 to about 25 wt.%, or about 0.001 to about 10 wt.%, of least one form of S-(+)abscisic acid (S-ABA); b) about 20 to 99.9 wt. %, or about 40 to 99.9 wt.%, of at least one organic solvent; c) optionally, 0 to about 50 wt. % of at least one non-aqueous co-solvent; d) optionally, 0 to about 20 wt. % at least one surfactant, e) optionally, additional plant growth regulator(s), f) optionally, additional plant nutrients; g) less than 0.1 wt.% antioxidant, h) less than 0.1 wt.% UV absorber, and i) ≤10 wt.% water, preferably ≤5 wt.% water. Preferably, the at least one organic solvent is at least one polyethylene glycol, and/or at least one glycol, and/or at least one lactamide, and/or at least one pentanoate. In one embodiment of the present invention, the at least one organic solvent is polyethylene glycol 200 (PEG 200). In one embodiment of the present invention, the at least one organic solvent is propylene glycol. In one embodiment of the present invention, the at least one organic solvent is N,N-dimethyl lactamide. In one embodiment of the present invention, the at least one organic solvent is methyl-5-dimethylamino-2-methyl-5-oxopentanoate.

(23) In a preferred embodiment, the non-aqueous liquid solution consists of, or consists essentially of: a) about 0.001 to about 40 wt. %, or about 0.001 to about 25 wt.%, or about 0.001 to about 10 wt.%, of least one form of S-(+) abscisic acid (S-ABA); b) about 20 to 99.9 wt. %, or about 40 to 99.9 wt.%, of at least one organic solvent; c) optionally, 0 to about 50 wt. % of at least one non-aqueous co-solvent; d) optionally, 0 to about 20 wt. % at least one surfactant, e) optionally, additional plant growth regulator(s), f) optionally, additional plant nutrients; g) less than 0.1 wt.% antioxidant, h) less than 0.1 wt.% UV absorber, i) ≤10 wt.% water, preferably ≤5 wt.% water; and j) <10 wt.% other ingredients, or <5 wt.% other ingredients, or <1 wt.% other ingredients. Wherein said “other ingredients” is any material which does not affect the basic and novel properties of the claimed solution. Such “basic and novel properties” include, but are not limited to, stability performance as provided in the EPA, Food and Agriculture Organization of the United Nations (FAO) and World Health Organization (WHO) Guidelines cited below. Preferably, the at least one organic solvent is at least one polyethylene glycol, and/or propylene glycol, and/or at least one lactamide, and/or at least one pentanoate. In one embodiment of the present invention, the at least one organic solvent is polyethylene glycol 200 (PEG 200). In one embodiment of the present invention, the at least one organic solvent is propylene glycol. In one embodiment of the present invention, the at least one organic solvent is N,N-dimethyl lactamide. In one embodiment of the present invention, the at least one organic solvent is methyl-5-dimethylamino-2-methyl-5-oxopentanoate.

(24) The following examples are intended to illustrate the present invention and to teach one of ordinary skill in the art how to make and use the invention. They are not intended to limit the invention or its protection in any way.

(25) Example 1: Stability of 1 wt% S-ABA Formulations

(26) TABLE-US-00001 TABLE 1 Ingredients (wt. %) A B C D (S)-ABA 1.11 1.11 1.11 1.11 Propylene Glycol 98.89 Polyethyene Glycol 200 98.89 Polyethyene Glycol 300 98.89 Polyethyene Glycol 400 98.89 Water Content Measured 0.20% 0.26% 0.17% 0.20%

(27) Four formulations of 1.11% S-ABA were prepared by dissolving S-ABA in various glycol solvents at room temperature without the use of stabilizers and antioxidants as set forth in Table 1 above. The EPA Guidelines on Stability that issued on Nov. 16, 2012 to the Office of Pesticide Programs (OPP) relating to “Accelerated Storage Stability and Corrosion Characteristics Study Protocol”, which are incorporated herein by reference, were followed using clear bottles to allow for UV radiation to be available to the solutions. As provided in the EPA, FAO, and WHO Guidelines, accelerated storage stability can be used to fulfill EPA and multi-national regulatory data requirements. OPP has determined that this study, conducted for 14 days at an elevated temperature (54° C.), provides adequate data in certain circumstances to allow EPA to make a regulatory finding regarding the stability of the product and the effect of the formulation on the product packaging. The Manual on the Development and Use of FAO and WHO Specifications for Pesticides, the contents of which are incorporated herein by reference, cites the tolerance for active ingredient in a formulated product is +/−5% for active ingredient content in formulation of 25-50%, +/−6% for active ingredient content in formulation of 10-25% and >+/−10% for formulations with less than 2.5% active content. The “Manual on the Development and Use of FAO and WHO Specifications for Pesticides” also provides that the average active ingredient content should not decline to less than 95% of the average content measured prior to the storage stability performed at 54±2° C. for 14 days. The results are summarized in Table 2 below:

(28) TABLE-US-00002 TABLE 2 Amount of S-ABA as Measured by HPLC Assay (wt. %) A B C D Initial  100%  100%  100%  100% 54 C/14 Days 92.7% 95.01% 98.18% 98.18%

(29) As Table 2 demonstrates, Formulation A, which contains propylene glycol showed significant degradation of S-ABA during Accelerated Storage Stability. Utilizing the current inventive solution, less than 5% degradation was observed.

(30) Example 2: Stability of 10+wt. % S-ABA Formulations

(31) TABLE-US-00003 TABLE 3 Ingredients (wt. %) E F G H (S)-ABA 10.26 10.21 10.28 10.26 Propylene Glycol 89.74 Polyethyene Glycol 200 89.79 Polyethyene Glycol 300 89.72 Polyethyene Glycol 400 89.74 Water Content Measured 0.67% 0.43% 0.43% 0.34%

(32) Four formulations of 10+wt. % S-ABA were prepared in various glycol solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the solvent at <90° C. as set forth in Table 3 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 4 below:

(33) TABLE-US-00004 TABLE 4 Amount of S-ABA (wt. %) as Measured by HPLC Assay E F G H Initial 10.26 10.21 10.28 10.26 Day 0 10.00 10.21 10.28 10.25 Day 14 9.71 9.95 9.91 9.85 % Loss from Initial 5.36 2.55 3.60 4.00

(34) As Table 4 demonstrates, Formulation F-H, which contains polyethylene glycol showed minimal degradation of S-ABA during Accelerated Storage Stability.

(35) Example 3: High Concentration ABA Solutions Using Glycol Solvents

(36) TABLE-US-00005 TABLE 5 Ingredients (wt. %) I J K L (S)-ABA 14.63 21.0 18.1 15.6 Propylene Glycol 85.37 Polyethyene Glycol 200 79.0 Polyethyene Glycol 300 81.9 Polyethyene Glycol 400 84.4 Water Content Measured 1.08% 0.33% 0.27% 0.54%

(37) Four formulations of >10 wt.% S-ABA were prepared in various glycol solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the solvent at <90° C. as set forth in Table 5 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 6 below:

(38) TABLE-US-00006 TABLE 6 Amount of S-ABA (wt. %) as Measured by HPLC Assay I J K L Initial 14.63 21.03 18.08 15.56 Day 0 13.78 20.72 17.86 15.08 54 C/14 Days 13.48 20.31 17.36 14.98 % Loss from Initial 7.86 3.42 3.98 3.73

(39) As Table 6 illustrates, Formulation J-L, which contains polyethylene glycol showed minimal degradation of S-ABA during Accelerated Storage Stability.

(40) Example 4: High Concentration ABA Solutions Using Co-Solvents

(41) TABLE-US-00007 TABLE 7 Ingredients (wt.%) M N O P Q R S T (S)-ABA 18.13    18.19    18.20    18.21    18.21    18.19    18.01    18.01    Polyethyene Glycol 200 73.68    73.63    73.62    73.62    73.61    73.63    73.79    73.79    Polyethyene Glycol 300  8.19    Polyethyene Glycol 400  8.18    Propylene Glycol  8.18    Methanol  8.18    Ethanol  8.18    Isopropanol  8.18    N,N-Dimethyl Lactamide  8.20    Methyl-5-  8.20    Dimethylamino-2- Methyl-5-Oxopentanoate Water Content Measured  0.32%  0.36%  0.38%  0.38%  0.37%  0.41%  1.11%  1.14%

(42) Eight formulations of ˜18 wt.% S-ABA were prepared in various co-solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the co-solvents at <90° C. as set forth in Table 7 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 8 below:

(43) TABLE-US-00008 TABLE 8 Amount of S-ABA (wt. %) as Measured by HPLC Assay M N O P Q R S T Initial 18.13 18.19 18.20 18.21 18.21 18.19 18.01 18.01 Day 0 18.10 18.19 18.21 18.81 18.58 18.67 17.90 17.91 54 C/ 17.96 17.68 17.65 18.48 18.40 18.44 17.66 17.56 14 Days % Loss  0.95  2.82  3.00  1.95  2.49 from Initial % Loss  1.75  0.97  1.23 from Day 0*

(44) As Table 8 illustrates, Formulation M-T, showed minimal degradation of S-ABA during Accelerated Storage Stability. Some evaporation was observed of the lower boiling co-solvents which led to slightly higher Day 0 results.

(45) Example 5: High Concentration ABA Solutions Using Higher Concentrations of Co-Solvents

(46) TABLE-US-00009 TABLE 9 Ingredients (wt. %) AA AB AC AD AE AF (S)-ABA 18.20    18.20    18.20    18.20    18.08    18.20    Polyethyene 53.17    53.17    53.17    53.17    53.25    53.17    Glycol 200 Polyethyene 28.63    Glycol 300 Polyethyene 28.63    Glycol 400 Propylene 28.63    Glycol Propylene 28.63    Carbonate N,N-Dimethyl 28.67    Lactamide Methyl-5- 28.63    Dimethylamino- 2-Methyl-5- Oxopentanoate Water Content  0.72%  0.69%  0.43%  0.31%  0.42%  0.49% Measured

(47) Six more formulations of ˜18 wt.% S-ABA were prepared utilizing higher concentrations of various co-solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the co-solvents at <90° C. as set forth in Table 9 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 10 below:

(48) TABLE-US-00010 TABLE 10 Amount of S-ABA (wt. %) as Measured by HPLC Assay AA AB AC AD AE AF Initial 18.20 18.20 18.20   18.20 18.08 18.20 Day 0 18.08 18.20 18.20   18.20 18.08 18.20 54 C/14 Days 17.39 17.34 17.75 1747    17.57 17.81 % Loss from Initial  4.44  4.72  2.49    4.01  2.80  2.14

(49) As Table 10 illustrates, Formulation AA-AF, showed minimal degradation of S-ABA during Accelerated Storage Stability.

(50) Example 6: High Concentration ABA Solutions Containing Various Concentrations of Water

(51) TABLE-US-00011 TABLE 11 Ingredients (wt. %) U V W X (S)-ABA 10.11 10.12 10.12 10.11 Polyethyene Glycol 89.89 89.88 89.88 89.89 200/Water Mix Water Content Measured 0.61% 2.13% 3.91% 7.26%

(52) Four formulations of ˜10 wt.% S-ABA were prepared in PEG 200 containing various amounts of water without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the co-solvents at <90° C. as set forth in Table 11 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 12 below:

(53) TABLE-US-00012 TABLE 12 Amount of S-ABA (wt. %) as Measured by HPLC Assay U V W X Initial 10.11 10.12 10.12 10.11 Day 0 10.11 10.14 10.14 10.34 54 C/14 Days 9.85 9.70 9.69 9.72 % Loss from Day 0 2.57 4.34 4.44 6.00

(54) As Table 12 illustrates, Formulation U-W, showed minimal degradation of S-ABA during Accelerated Storage Stability. Concentrations of water above 5% as in Formulation X demonstrated >5% loss of ABA. Some evaporation was observed of water which led to slightly higher Day 0 results.

(55) Example 7: High Concentration ABA Solutions Using Non-Glycol Solvents

(56) TABLE-US-00013 TABLE 13 Ingredients (wt. %) Y Z (S)-ABA 40.00 40.00 N,N-Dimethyl Lactamide 60.00 Methyl-5-Dimethylamino-2-Methyl-5- 60.00 Oxopentanoate Water Content Measured 0.58% 0.39%

(57) Two formulations of ˜40 wt.% S-ABA were prepared in various non-glycol solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the solvent at <90° C. as set forth in Table 13 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 14 below:

(58) TABLE-US-00014 TABLE 14 Amount of S-ABA (wt. %) as Measured by HPLC Assay Y Z Initial 40.06 40.05 Day 0 39.98 39.95 54 C/14 Days 38.46 38.66 % Loss from Initial  4.00  3.48

(59) As Table 14 illustrates, Formulation Y and Z, which contains high ABA concentrations and are using non-glycol solvents showed minimal degradation of S-ABA during Accelerated Storage Stability.

(60) Example 8: High Concentration ABA Solutions with Various Surfactants

(61) TABLE-US-00015 TABLE 15 Ingredients (wt. %) AG AH AI AJ (S)-ABA 20.00 20.01 20.03 20.02 Polyethyene Glycol 200 75.00 74.99 69.97 69.98 Organomodified Trisiloxanes 5.0 (Silicone Based) Di -2-Ethylhexyl Sulfosuccinate 5.0 Polysorbate 20 (Sorbitan Derivative) 10.00 Alcohol Ethoxylate/ 10.00 Phenolated Ethoxylates Water Content Measured 0.89% 0.96% 0.42% 0.55%

(62) Four formulations of ˜20 wt.% S-ABA were prepared in PEG 200 containing 5-10% of various types of surfactants without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the co-solvents at <90° C. as set forth in Table 15 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 16 below:

(63) TABLE-US-00016 TABLE 16 Amount of S-ABA (wt. %) as Measured by HPLC Assay AG AH AI AJ Initial 20.02 20.01 20.03 20.02 Day 0 20.00 20.01 19.86 19.94 54 C./14 Days 19.82 19.82 19.12 19.08 % Loss from Initial  0.98  0.94  4.54  4.72

(64) As Table 16 illustrates, Formulation AG thru AJ, which contains high ABA concentrations and various types of surfactants showed minimal degradation of S-ABA during Accelerated Storage Stability.

(65) Example 9: High Concentration ABA Solutions with Various Plant Growth Regulators

(66) TABLE-US-00017 TABLE 17 Ingredients (wt. %) AK AL AM AN (S)-ABA 10.11    10.12    10.12    10.12    Polyethyene Glycol 200 88.89    88.87    87.37    79.81    Forchlorfenuron (CPPU)  1.00    6-Benzlaminopurine (6-BA)  1.01     2.51    Gibberellic Acid (GA3) 10.07    Water Content Measured  0.40%  0.48%  0.54%  1.44%

(67) Four formulations of ˜10 wt.% S-ABA were prepared in PEG 200 containing various types of plant growth regulators (PGRs) without the use of stabilizers and anti-oxidants by heating the S-ABA and plant growth regulator above room temperature in the co-solvents at <90° C. as set forth in Table 17 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 18 below:

(68) TABLE-US-00018 TABLE 18 Amount of S-ABA (wt. %) as Measured by HPLC Assay AK AL AM AN Initial 10.11 10.12 10.12 10.12 Day 0 10.10 10.12 10.12  9.97 54 C./14 Days  9.97  9.96  9.99  9.95 % Loss from Initial  1.39  1.58  1.28  1.66

(69) TABLE-US-00019 Amount of Additional (wt. %) as Measured by HPLC Assay AK AL AM AN (CPPU) (6-BA) (6-BA) (GA3) Initial 1.00 1.01 2.51 10.07 Day 0 1.00 1.01 2.51 10.07 54 C./14 Days 0.96 1.01 2.51 10.05 % Loss from Initial 3.95 0.00 0.00  0.29

(70) As Table 18 illustrates, Formulation AK thru AN, which contains high ABA concentrations and various PGRs showed minimal degradation of S-ABA and the respective PGR during Accelerated Storage Stability.

(71) Example 10: High Concentration ABA Solutions with Various Plant Nutrients

(72) TABLE-US-00020 TABLE 19 Ingredients (wt. %) AO AP (S)-ABA 10.35    10.33    Polyethyene Glycol 200 83.98    88.87    Boric Acid  5.67    Sodium Molybdate  2.96    Water Content Measured  6.40%  5.17%

(73) Two formulations of ˜10 wt.% S-ABA were prepared in PEG 200 containing various types of plant nutrients without the use of stabilizers and anti-oxidants by heating the S-ABA and plant growth regulator above room temperature in the co-solvents at <90° C. as set forth in Table 19 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 20 below:

(74) TABLE-US-00021 TABLE 20 Amount of S-ABA (wt. %) as Measured by HPLC Assay AO AP Initial 10.35 10.33 Day 0 10.32 10.29 54 C./14 Days 10.07  9.84 % Loss from Initial  2.73  4.71

(75) As Table 20 illustrates, Formulation AO and AP, which contains high ABA concentrations and various nutrients showed minimal degradation of S-ABA and the respective PGR during Accelerated Storage Stability.

(76) Example 11: High Concentration ABA Solutions in N,N-Dimethyl Lactamide and Co-Solvents

(77) TABLE-US-00022 TABLE 21 Ingredients (wt. %) AQ AR AS AT AU (S)-ABA 30.33    30.35    30.32    30.34    30.34    N,N-Dimethyl 62.70    62.70    62.69    62.71    62.70    Lactamide Polyethyene  6.97    Glycol 200 Polyethyene  6.95    Glycol 300 Polyethyene  6.99    Glycol 400 Propylene Glycol  6.95    Propylene  6.96    Carbonate Water Content  0.85%  1.95%  1.85%  0.46%  0.44% Measured

(78) Five formulations of ˜30 wt.% S-ABA were prepared in N,N-Dimethyl Lactamide with various co-solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the co-solvents at <90° C. as set forth in Table 21 above. Accelerated

(79) Stability Testing was also performed on these solutions. The results are summarized in Table 22 below:

(80) TABLE-US-00023 TABLE 22 Amount of S-ABA (wt. %) as Measured by HPLC Assay AQ AR AS AT AU Initial 30.33    30.35    30.32    30.34    30.34    Day 0 30.33    30.33    30.32    30.33    30.34    54 C./14 Days 30.09    29.16    29.64    29.27    30.25    % Loss from Initial  0.79%  3.86%  2.24%  3.49%  0.30%

(81) As Table 22 shows, Formulation AQ-AU, which contains N,N-Dimethyl Lactamide and other cosolvents showed minimal degradation of S-ABA during Accelerated Storage Stability.

(82) Example 11: High Concentration ABA Solutions in Methyl-5-Dimethylamino-2-Methyl-5-Oxopentanoate and Co-Solvents

(83) TABLE-US-00024 TABLE 23 Ingredients (wt. %) AV AW AX AY AZ (S)-ABA 30.34    30.34    30.34    30.34    30.33    Methyl-5- 62.70    62.70    62.69    62.71    62.70    Dimethylamino-2- Methyl-5- Oxopentanoate Polyethyene Glycol 200  6.96    Polyethyene Glycol 300  6.96    Polyethyene Glycol 400  6.97    Propylene Glycol  6.95    Propylene Carbonate  6.97    Water Content  0.54%  0.56%  0.50%  0.61%  0.46% Measured

(84) Five formulations of ˜30 wt.% S-ABA were prepared in Methyl-5-Dimethylamino-2-Methyl-5-Oxopentanoate with various co-solvents without the use of stabilizers and anti-oxidants by heating the S-ABA above room temperature in the co-solvents at <90° C. as set forth in Table 23 above. Accelerated Stability Testing was also performed on these solutions. The results are summarized in Table 24 below:

(85) TABLE-US-00025 TABLE 24 Amount of S-ABA (wt. %) as Measured by HPLC Assay AV AW AX AY AZ Initial 30.34    30.34    30.34    30.34    30.33    Day 0 30.33    29.96    30.33    30.27    30.33    54 C./7 Days 30.29    29.76    30.16    30.17    30.27    % Loss from Initial  0.13%  0.67%  0.56%  0.33%  0.20%

(86) As Table 24 demonstrates, Formulation AV-AZ, which contains Methyl-5-Dimethylamino-2-Methyl-5-Oxopentanoate and other cosolvents showed minimal degradation of S-ABA during Accelerated Storage Stability.

(87) Example 13: Performance of Current Invention in the Coloring of Grapes

(88) As indicated, (S)-(+)-abscisic acid formulations are used commercially to encourage coloring of fruits, specifically, table grapes. An experiment was done in Los Lirios, Chile on Crimson Seedless grapes. Two applications during normal application timings (January 22 and February 5.sup.th) were done using Valent's Protone SL (10% S-ABA) vs Stoller's Experimental SL (18% S-ABA) against a water/surfactant control. The rates were adjusted to the concentration of the S-ABA in the Soluble Liquid (SL) formulation:

(89) TABLE-US-00026 Water Content Active Treatments of Solution Ingredient Rate Timing Control N/A N/A (Water + Surfactant) Commercial   >85 wt. % 10.05 wt, % 400 Berries (Valent′s S-ABA cc/Hectare Beginning Protone SL) to Touch Stoller   0.69 wt. % 17.79 wt. % 200 Berries (Experimental) S-ABA cc/Hectare Beginning to Touch

(90) The results of the trials demonstrated a significantly higher fruit weight and berry size with the current inventive solution compared to the commercial solution. The current inventive solution did not show any statistical difference from the Control.

(91) TABLE-US-00027 Results: Summary of Fruit Weight and Berry Size Treatments Fruit Weight (g) Berry Size (mm) Control 7.09 a 19.39 a Commercial 6.2 b 18.76 b** Stoller 7.26* a 19.39 a *P-Value: < 0.0001 **P Value: < 0.0001

(92) Additionally, color intensity and covering color were significantly improved using the current inventive solution over the commercial treatment.

(93) TABLE-US-00028 Results: Summary of Color Intensity with Time Dates Treatments 22-Jan. 28-Jan. 5-Feb. 5-Mar. Control 1.27 a 2.10 a 2.75 a 3.21 a Commercial 1.19 a 2.27 a 3.10 b 3.27 a Stoller 1.33 a 2.77 b* 3.67 c** 4.33 b*** *P-Value: < 0.0001 **P Value: < 0.0001 ***P Value: < 0.0001 #Color Intensity based on Red Globe Color Index (CIRG)

(94) TABLE-US-00029 Results: Summary of Covering Color with Time Dates Treatments 22-Jan. 28-Jan. 5-Feb. 5-Mar. Control 1.27 a 2.00 a 3.00 a 4.33 a Commercial 1.20 a 2.13 a 3.17 a 4.23 a Stoller 1.19 a 2.56 b* 4.02 b** 4.6 b*** *P-Value: < 0.0001 **P Value: < 0.0001 ***P Value: < 0.01 #Color Covering based on the following Category Assignment:

(95) TABLE-US-00030 % of Grapes Category Colored 0     0% 1  1-30% 2 31-60% 3 91-99% 4   100%

(96) As shown in FIG.1, the current invention also significantly demonstrated greater anthocyanin content in the grapes than both the commercial and control treatment.

(97) In summary, the current invention at a lower effective dosage rate to the commercial treatment demonstrated statistically significant better fruit weight, higher color intensity, higher color coverage, and anthocyanin.

(98) Although the present invention has been disclosed in terms of a preferred embodiment, it will be understood that numerous additional modifications and variations could be made thereto without departing from the scope of the invention as defined by the following claims.